The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan

Chaudhury, Chaity, Mehnaz, Samina, Robinson, John M., Hayton, William L., Pearl, Dennis K., Roopenian, Derry C., Anderson, Clark L.·2003·The Journal of Experimental Medicine
DOI 10.1084/jem.20021829

Cited by (642)

Items 601–642 of 642

  1. Self-Delivery Drug Amphiphilies In Chemotherapy And Immunotherapy
    Jingchao Xi · 2019 · Human Biology
  2. ADME of Biologicals and New Therapeutic Modalities
    R. Foti · 2021 · Elsevier eBooks
  3. An in vivo model of echovirus-induced meningitis in neonates
    Alexandra I. Wells, Carolyn B. Coyne · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  4. Session 3: Cancer – II
    2004 · Human Antibodies
  5. Faculty Opinions recommendation of Albumin in decompensated cirrhosis: new concepts and perspectives.
    Doug Dieterich, Clara Rodriguez Rivas · 2021 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  6. Factor VIIa
    Man‐Chiu Poon · 2019 · Elsevier eBooks
  7. Antibody interactions with the immune system
    2012 · Elsevier eBooks
  8. Genetically Engineered Antibody Molecules
    Sherie Leaver Morrison, E.M. Yoo · 2014 · Elsevier eBooks
  9. FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features
    Dae Hyun Song, Juseok Yang, Cho Hee Kim, Min Hye Kim, Jae Yoon Jo, Jong Chul Baek · 2023 · Diagnostics
  10. Novel 3D Approach to Model Non-Alcoholic Fatty Liver Disease using human Pluripotent Stem Cells
    Carola Maria Morell, Samantha Grace Tilson, Rute A. Tomaz, Arash Shahsavari, Andi Munteanu, Giovanni Canu, Brandon Tyler Wesley, Marion Perrin, Imbisaat Geti, Subhankar Mukhopadhyay et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Identification of Four Mouse FcRn Splice Variants and FcRn-Specific Vesicles
    George Haddad, Judith Tamara Blaine · 2024 · Cells
  12. Albumin-based drug/gene delivery systems
    Wenjie Zhang, Jiayi Men, Jiong Zhou, Guocan Yu · 2025 · Scientia Sinica Chimica
  13. Possible IgG transportation mechanism mediated by neonatal Fc receptor expressed in gingival epithelial cells
    Kazuhisa Ouhara, Mikihito Kajiya, Philip Stashenko, Martin A. Taubman, Toshihisa Kawai · 2010 · Springer eBooks
  14. Additional file 1 of Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation
    Go, Eun Byeol, Jae Hun Lee, Jeong Haeng Cho, Kwon, Na Hyun, Choi, Jong-il, Kwon, Inchan · 2024 · Figshare
  15. Additional file 1 of Single protein encapsulated SN38 for tumor-targeting treatment
    Changjun Yu, Faqing Huang, Kinsley Wang, M. C. Liu, Chow, Warren A., Xiang Ling, Fengzhi LI, Jason Causey, Huang, Xiuzhen, Galen Cook‐Wiens et al. · 2023 · Figshare
  16. FcRn inhibitors: A new era in neurotherapeutics
    James F. Howard, Jeffrey T. Guptill · 2026 · Handbook of clinical neurology
  17. Polymeric Delivery of DNA‐Encoded Biologics
    Jeffrey Ting, Peter A. Dykeman-Bermingham, Caroline E. Cairns, Shannon R. Petersen, Nathaniel J. Snell, Rakshitha Pandulal Miskin, John D. Fisher, Shashi K. Murthy, Sean Kevlahan, Gustavo Guzman et al. · 2026 · Macromolecular Chemistry and Physics
  18. Cryo-EM elucidates the interaction mechanism of ozoralizumab, a humanized anti-TNFα NANOBODY® compound
    Masashi Mima, K Sato, Takeshi Yokoyama, Chiemi Mishima-Tsumagari, Tatsuya Ohnuki, Yoshikazu Tanaka, Kunihiko Iwamoto · 2026 · Biochemical and Biophysical Research Communications
  19. Miniaturized IL-2/anti-IL-2 immunocytokines selectively activate and support the in vivo persistence of regulatory T cells
    Charina S. Fabilane, Jakub Tomala, Paul M. Zdinak, Bailey T. Chalmers, A Carson Stephenson, Emily C. Ariail, Ella C. Teeley, Alok V. Joglekar, Jamie B. Spangler · 2026 · Frontiers in Immunology
  20. Reduction in Synaptic Vesicle Protein Abundance but Increased Amounts of Nsg2 and Lpcat1 in Cerebral Cortices Without the Endosomal SNARE Proteins Vti1a and Vti1b
    Julia Gottschalk, Katharina Kotschnew, Julia Hahn, Thomas Patschkowski, Gabriele Fischer von Mollard · 2026 · PROTEOMICS
  21. Optimizing human FcRn mouse models to improve pharmacokinetic evaluation of antibody drug candidates
    Gregory J. Christianson, Zachary M. Howard, Samantha Kenney, Emily Lowell, NIJAGUNA BETHUR, Derry C. Roopenian, Elena Gonzalo-Gil · 2026 · mAbs
  22. Expression du récepteur FcRn et pharmacocinétique des anticorps thérapeutiques
    Christophe Passot · 2014
  23. Etapes précoces de l'infection du virus de l'hépatite C : endocytose et rôle potentiel du FcRn dans la modulation de sa neutralisation
    Anthony Morel · 2016
  24. Stratégies innovantes de bioconjugaison pour des applications en thérapie ciblée et en imagerie
    Camille Martin · 2017
  25. Déterminants moléculaires de la pharmacocinétique des anticorps thérapeutiques
    Guillaume Brachet · 2017
  26. When engineering new recombinant factor IX molecules meets gene therapy : improvement of factor IX plasma level in patients with haemophilia B?
    Sandra Le Quellec · 2018 · theses.fr (ABES)
  27. Etude du niveau d'expression du FcRn sur la réponse anti-tumorale : impact sur les cellules Natural Killer (NK)
    Diana Cadena Castaneda · 2018 · theses.fr (ABES)
  28. Characterizing the role of IgG antibodies in anaphylaxis
    Bianca Balbino · 2019 · theses.fr (ABES)
  29. Impact de l’inflammation sur la pharmacocinétique des médicaments
    Florian Simon · 2020 · theses.fr (ABES)
  30. Implication de la protéine ClC-5 dans la physiopathologie de la maladie de Dent : analyse de mutants pathogènes et caractérisation d’un modèle de souris transgéniques
    Imene Bouchra Sakhi · 2021
  31. Elimination des anticorps monoclonaux par leur cible : étude par modélisation pharmacocinétique
    Olivier Le Tilly · 2022
  32. Développement de systèmes moléculaires programmés pour le ciblage thérapeutique du microenvironnement tumoral
    Rémi Châtre · 2021
  33. Variation de l'expression du FcRn au cours de la différenciation des macrophages : rôle de l'autophagie
    Juliette Lamamy · 2022 · theses.fr (ABES)
  34. Assessing the clinical impact of albumin infusion in critically ill ICU patients with acute myocardial infarction and hypoalbuminemia: a retrospective propensity score-matched cohort study
    Ye Ding, K.J. Wang, Da Xu, Xiaojin Xu, Zhuyang Shen, Xiaofei Huang, Dan Huang · 2026 · BMC Cardiovascular Disorders
  35. Side-by-Side Comparison of Different Thiol Bioconjugation Strategies for the Chemoselective Radiolabeling of Human Serum Albumin with Zirconium-89
    Julia Kronberger, Barbora Neužilová, Anja Federa, Manuel Tieber, Amando Palombo, Marie Brandt, Petra Heffeter, Christian R. Kowol, Miloš Petřík, Thomas L. Mindt · 2026 · ACS Bio & Med Chem Au
  36. Systemic Inflammation as a Modulator of FcRn-dependent IgG Pharmacokinetics: Implications for Broadly Neutralising Antibody Efficacy in HIV Prevention
    Andile Khumalo, Sanjali Pillay, Jivanka Mohan, Sharana Mahomed, Derseree Archary · 2026 · Current HIV/AIDS Reports
  37. FcRn inhibitors in the treatment of CIDP
    Alexander H. Morrison, Jeffrey A. Allen · 2026 · Journal of the Neurological Sciences
  38. Lipidation of the KV1.3 blocking peptide HsTX1[R14A] alters its pharmacokinetics and biodistribution
    Lihuan Lin, Thomas R. Mitchell, Karoline Sanches, Mohammad Abdallah, Yuxiang Ren, Muhammad Asim Farooq, Hefeng Song, Jinghan Qu, Zengke Chen, William De Nardo et al. · 2026 · International Journal of Pharmaceutics
  39. Albumin uptake through FcRn promotes tumor-associated macrophage maturation and albumin-bound immunotherapy response
    Huiyu Hu, Fangchao Jiang, Seong Jin Park, Xinying Ge, Marie Goemans, Mikyung Kang, Ella Scott, Dennis H. Gong, Jeremy M. Quintana, Victoria E. Rodriguez et al. · 2026 · Cell Reports
  40. Population Pharmacokinetics of Intravenous and Subcutaneous Belimumab, and Clinical Response Prediction in Chinese Pediatric Patients with Systemic Lupus Erythematosus
    Junyi Wu, Richard Dimelow, Scott F. Marshall, Xuan Zhou · 2026 · Drugs in R&D
  41. A human erythropoietin-albumin fusion protein tailored for enhanced plasma half-life and delivery across mucosal surfaces
    Aina Karen Anthi, Daniela Bejan, Simone Mester, NIJAGUNA BETHUR, Elena Gonzalo-Gil, Sopisa Benjakul, Kristin Hovden Aaen, Tilman Schlothauer, Inger Sandlie, Jan Terje Andersen · 2026 · Nature Communications
  42. A modular nucleic acid-albumin biomolecular platform for multifunctional drug designs
    Elisabeth Fuchs, Anders Dinesen, Sui Ching Ong, Y ZHANG, Aina Karen Anthi, Imke Rudnik‐Jansen, Ole Aalund Mandrup, Marwa Elkhashab, Archie Wall, Esben Skipper Sørensen et al. · 2026 · Journal of Controlled Release